Baker & McKenzie
Learn about us Locally »
English (Change Language)
Baker & McKenzie
Learn about us Locally
Combining the knowledge of local laws and cultures with a global reach is just one of the ways Baker & McKenzie separates itself from other firms. Our genuinely global perspective allows us to operate without boundaries around the world, in every jurisdiction that is important to your business.

Select a region or country to learn about on-the-ground resources immersed in the local culture or Learn about us Globally to view our talent and services worldwide.

When content is available in multiple languages, please select your preference on the right.

Hadiputranto, Hadinoto & Partners Successfully Advised Pfizer Inc (US), Pfizer Overseas LLC (US), Pfizer Global Trading (Ireland), and Pfizer Corporation Panama (Panama) on their Challenge of the Indonesian Anti-Monopoly Commission (KPPU) Decision

Case Announcement
15 September 2011
Jakarta, Indonesia, 15 September 2011 – Hadiputranto, Hadinoto & Partners (HHP) successfully advised Pfizer Inc (US) , Pfizer Overseas LLC (US), Pfizer Global Trading (Ireland), and Pfizer Corporation Panama (Panama) on their challenge of the Indonesian Anti-Monopoly Commission (KPPU) decision in which Pfizer Inc (US), Pfizer Overseas LLC (US), Pfizer Global Trading (Ireland), Pfizer Corporation Panama (Panama), PT Pfizer Indonesia, and PT Dexa Medica were found guilty of price fixing (Article 5), cartel (Article 11), illegal agreement with foreign parties (Article 16) and abuse of dominant position (Article 25(1)a) under the Law No. 5 of 1999 on the Prohibition of Monopolistic Practices and Unfair Business Competition with regards to the manufacture and sale of an antihypertensive drug.

This was the first Indonesian cartel case involving the pharmaceutical industry. KPPU held that several Pfizer entities and the Indonesian pharmaceutical company, PT Dexa Medica, conspired to regulate the production and the pricing of  the antihypertensive drugs Norvask and Tensivask, causing the prices to be excessive for consumers. KPPU therefore imposed a fine on each of the Pfizer entities and PT Dexa Medica and issued an order to lower the price of Norvask by 65% and Tensivask by 60%.

HHP successfully argued before the Central Jakarta District Court that the KPPU findings were baseless and lacked evidence. There was no price fixing or cartel, and the prices of Norvask and Tensivask were the reflection of the market mechanism. HHP asked the Court for an additional examination to hear several expert testimonies to support our objection. The Court found in favor of all Pfizer entities and PT Dexa Medica and revoked the KPPU decision in its entirety, in agreement with HHP’s arguments.

Wimbanu Widyatmoko, Managing Partner of HHP said, “This is a high profile case and a very complex one. On completion, we were pleased when we heard that the Jakarta District Court overruled the decision of the Indonesian Anti-Monopoly Commission against the Pfizer group of companies on the alleged violation of the Indonesian anti-monopoly laws. This case would cement Pfizer's existing position in Indonesia.”

The HHP team also involved other partners including Mochamad Fachri, who led on the deal from the Firm’s Trade & Anti-Monopoly Practice Group; Hendronoto Soesabdo from the Firm’s Commercial Disputes Practice Group; and associates from both practice groups.
For further information, please contact:
Communications Manager, Asia Pacific
+852 2846 1759
Search Globally

Search Globally
Alphabetical by Last Name
Every day our more than 4,000 lawyers, economists, tax advisors and other professionals share insights and best practices across borders and practices. We speak more than 75 languages and represent more than 55 nationalities, and the close relationships among our people fosters the trust needed to develop and deliver world-class solutions to multinational clients.

We share an uncompromising commitment to excellence, which explains why more of our lawyers are included as leading lawyers in the Chambers Global Guide to the World’s Best Lawyers than any other Global 20 law firm.

To find a Baker & McKenzie lawyer or other professional, enter a search parameter to the left.
Passionately global
We are passionately global — it's in our DNA.

We started with a vision of going global and were in eight countries before our 10th anniversary. Today we have 76 offices in 47 countries -- including the emerging markets so important to the growth of your business.
We offer world-class career opportunities around the globe, while our entrepreneurial culture makes Baker & McKenzie a unique place to develop professionally.

Explore us Locally by selecting a region, country or office below, or select Submit to view our site Globally.